Evidence map›Paper›PMID 41055594›Full record

ReviewMelanoma management2025

Bridging gaps throughout a patient's journey with melanoma: a systematic review.

Adil Amarsi, Joy Xu, Josh Chan, Yuan Chun Jiang, Ahmad Zobair Omar, Yasmin Meghdadi, Aashita Doshi, Alison Xie, Alyssa Wu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Melanoma management, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adil AmarsiFaculty of Health Sciences, McMaster University, Hamilton, ON, Canada.ORCID 0009-0005-5686-9041
Joy XuDepartment of Medicine, University of California Los Angeles, Los Angeles, CA, USA.ORCID 0000-0002-3233-2371
Josh ChanSchulich School of Medicine & Dentistry, Western University, London, ON, Canada.ORCID 0009-0003-4336-3733
Yuan Chun JiangSchulich School of Medicine & Dentistry, Western University, London, ON, Canada.ORCID 0009-0008-3030-794X
Ahmad Zobair OmarDepartment of Kinesiology, McMaster University, Hamilton, ON, Canada.ORCID 0009-0000-0541-1886
Yasmin MeghdadiFaculty of Health Sciences, McMaster University, Hamilton, ON, Canada.ORCID 0009-0003-1603-9794
Aashita DoshiSchool of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX, USA.ORCID 0009-0008-6700-8724
Alison XieSchulich School of Medicine & Dentistry, Western University, London, ON, Canada.ORCID 0009-0001-9865-9465
Alyssa WuSchulich School of Medicine & Dentistry, Western University, London, ON, Canada.ORCID 0000-0003-4842-0816

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMelanoma is one of the most fatal skin cancers, with rising incidence and mortality worldwide. From diagnosis to treatment, patient experiences often involve anxiety, symptom burden, and limited access to information which profoundly impacts health outcomes.

objectiveThis systematic review aims to identify and analyze major barriers melanoma patients face throughout their healthcare journey.

methodsStudies were identified from PubMed, Scopus, Web of Science, Embase, and Cochrane Library, supplemented by manual hand-searching. Eligible studies focused on the experiences of melanoma patients, addressed knowledge gaps and barriers to care throughout the patient journey, and were published in English between 2013 and 2023. Screening and extraction were conducted independently and in duplicate. The methodological quality of the included studies was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria.

resultsOut of 2,257 screened articles, 183 met the inclusion criteria. Studies were categorized into four major themes: intersectionality, treatment, diagnosis/prognosis, and patient/societal burden. Commonly explored subcategories included self-examination, risk factors, and drug efficacy.

conclusionsMelanoma patients experience significant gaps throughout their healthcare journey. Identifying areas of improvement in current practices is the first step toward developing targeted solutions that improve the patient experience and quality of life.

Indexed as

healthcare disparitiesMelanomapatient-centered carepatient journeyskin cancer

Identifiers

PMID41055594
PMCPMC12505521

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.